文献速递胃肠动力与功能性疾病

脑肠互动障碍的药理学、药代动力学与药物基因组学

Pharmacological, Pharmacokinetic, and Pharmacogenomic Aspects of Disorders of Gut-Brain Interaction.
PubMed 文献 · Gastroenterology · 2026-02-20

本文综述了与脑肠互动障碍(DGBI)相关的临床前、动物及人体药理学、药代动力学和药物基因组学研究。文章回顾了内脏痛、动力异常和上皮转运的动物模型及人体动力和感觉模型在DGBI药物开发中的效用,重点关注结直肠和胃生物标志物。还总结了基于适应症(消化不良、便秘、腹泻和内脏痛)的DGBI治疗药物的临床药理学,并介绍了用于IBS个体化治疗的生物标志物及未来研究方向。

要点

  • 动物模型和人体模型可用于DGBI药物开发,结直肠和胃生物标志物有潜在价值。
  • 药物基因组学基于药物代谢,在IBS治疗靶点上有少量药物遗传学例子。
  • DGBI药物治疗按适应症分为精神药物和非精神药物,需个体化选择。

核心结论

  • 综述了DGBI相关药理学、药代动力学和药物基因组学,强调生物标志物在个体化治疗中的潜力。

研究设计与样本

  • 文献综述,涵盖临床前、动物和人体药理学、药代动力学及药物基因组学研究。

主要发现

  • 动物模型用于研究内脏痛、动力异常和上皮转运;人体模型评估动力和感觉。
  • 结直肠和胃生物标志物可用于DGBI药物开发。
  • 药物基因组学基于药物代谢,IBS治疗靶点有少量药物遗传学例子。
  • DGBI治疗药物按适应症(消化不良、便秘、腹泻、内脏痛)分为精神药物和非精神药物。

临床怎么用

  • 临床可参考生物标志物个体化IBS治疗,并根据适应症选择精神药物或非精神药物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We conducted a literature review of preclinical, animal and human pharmacology, pharmacokinetics, and pharmacogenomics related to disorders of gut-brain interaction (DGBI). This article reviews animal models of visceral pain, abnormal motility, and epithelial transport, and human models of motility and sensation and their utility in drug development for DGBI with focus on colorectal and gastric biomarkers. We highlight preclinical studies related to pharmacology, pharmacokinetics, and toxicology required for development of novel therapeutic agents, and principles of pharmacogenomics based on drug metabolism and the few examples of pharmacogenetics related to targets in treatment of IBS. Finally, we summarize the human pharmacology of medications used for treatment of DGBI based on the individual indications - specifically psychopharmacologic and nonpsychotropic agents for DGBI associated with dyspepsia, constipation, diarrhea, and visceral pain, as well as introduction of biomarkers for individualizing therapy for IBS and recommendations for future research.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Camilleri M, Sarnelli G, Andresen V, et al. Pharmacological, Pharmacokinetic, and Pharmacogenomic Aspects of Disorders of Gut-Brain Interaction. Gastroenterology. 2026. PMID: 42031437. doi:10.1053/j.gastro.2026.02.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。